Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration

Joseph R Smith1, Sean Maguire, Lesley A Davis

  • 1Department of Surgery, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Addenbrooke's Hospital, Hills Road, Cambridge CB2 OXY, United Kingdom. jrs68@cam.ac.uk

Stem Cells (Dayton, Ohio)
|November 21, 2007
PubMed
Summary

Targeting the AAVS1 locus in human embryonic stem cells (hESCs) with adeno-associated virus type 2 (AAV2) technology improves transgene expression stability. This method reduces silencing and variegation, crucial for reliable gene function studies and potential clinical applications.

Related Concept Videos